Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging | 37 | 2024 | 3603 | 3.540 |
Why?
|
Brain Neoplasms | 11 | 2023 | 1315 | 2.680 |
Why?
|
Meningitis, Bacterial | 3 | 2022 | 96 | 1.960 |
Why?
|
Child Abuse | 5 | 2022 | 196 | 1.680 |
Why?
|
Ganglioglioma | 3 | 2020 | 22 | 1.640 |
Why?
|
Neuroimaging | 13 | 2023 | 341 | 1.570 |
Why?
|
Radiation Injuries | 3 | 2018 | 143 | 1.490 |
Why?
|
Proton Therapy | 3 | 2018 | 126 | 1.460 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2023 | 142 | 1.430 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 373 | 1.410 |
Why?
|
Cranial Nerves | 2 | 2024 | 19 | 1.320 |
Why?
|
Craniocerebral Trauma | 4 | 2022 | 139 | 1.300 |
Why?
|
Astrocytoma | 3 | 2019 | 107 | 1.200 |
Why?
|
Supratentorial Neoplasms | 2 | 2020 | 37 | 1.090 |
Why?
|
Contrast Media | 7 | 2021 | 480 | 1.080 |
Why?
|
Tomography, X-Ray Computed | 14 | 2022 | 2091 | 1.080 |
Why?
|
Sensitivity and Specificity | 11 | 2022 | 2057 | 1.040 |
Why?
|
Infant | 31 | 2024 | 12597 | 0.990 |
Why?
|
Pons | 1 | 2024 | 33 | 0.920 |
Why?
|
Retrospective Studies | 35 | 2024 | 16362 | 0.920 |
Why?
|
Sinus Thrombosis, Intracranial | 5 | 2024 | 48 | 0.910 |
Why?
|
Hydrocephalus | 6 | 2024 | 245 | 0.900 |
Why?
|
Child, Preschool | 30 | 2024 | 14142 | 0.870 |
Why?
|
Gadolinium | 2 | 2021 | 109 | 0.840 |
Why?
|
Muscle Weakness | 1 | 2024 | 84 | 0.840 |
Why?
|
Ataxia | 2 | 2024 | 170 | 0.830 |
Why?
|
Essential Tremor | 1 | 2024 | 89 | 0.820 |
Why?
|
Brain | 12 | 2024 | 3012 | 0.820 |
Why?
|
Child | 43 | 2024 | 24606 | 0.810 |
Why?
|
Streptococcus agalactiae | 2 | 2022 | 99 | 0.790 |
Why?
|
Female | 51 | 2024 | 66888 | 0.720 |
Why?
|
Encephalitis | 1 | 2022 | 109 | 0.720 |
Why?
|
Male | 48 | 2024 | 61628 | 0.710 |
Why?
|
Magnetic Resonance Angiography | 3 | 2019 | 164 | 0.680 |
Why?
|
Humans | 76 | 2024 | 125439 | 0.670 |
Why?
|
Diagnosis, Differential | 11 | 2022 | 1899 | 0.670 |
Why?
|
Ear, Inner | 1 | 2020 | 49 | 0.670 |
Why?
|
Deep Brain Stimulation | 1 | 2024 | 411 | 0.620 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2020 | 143 | 0.600 |
Why?
|
Skull Fractures | 1 | 2018 | 43 | 0.600 |
Why?
|
Joint Diseases | 1 | 2018 | 33 | 0.590 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2019 | 225 | 0.590 |
Why?
|
Stroke | 6 | 2023 | 979 | 0.590 |
Why?
|
Hemangioma, Capillary | 1 | 2017 | 17 | 0.570 |
Why?
|
Cerebral Arterial Diseases | 1 | 2017 | 5 | 0.560 |
Why?
|
Neoplasm Grading | 2 | 2015 | 276 | 0.560 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 17 | 0.550 |
Why?
|
Escherichia coli Infections | 1 | 2019 | 189 | 0.550 |
Why?
|
Cerebral Hemorrhage | 1 | 2018 | 143 | 0.550 |
Why?
|
Cerebral Arteries | 1 | 2017 | 83 | 0.540 |
Why?
|
Streptococcal Infections | 1 | 2019 | 241 | 0.530 |
Why?
|
Glioma | 1 | 2021 | 512 | 0.520 |
Why?
|
Adolescent | 20 | 2024 | 19447 | 0.500 |
Why?
|
Orbit | 2 | 2017 | 102 | 0.500 |
Why?
|
Meningeal Neoplasms | 2 | 2017 | 192 | 0.490 |
Why?
|
Blood Volume Determination | 1 | 2014 | 10 | 0.470 |
Why?
|
Rhabdomyosarcoma | 1 | 2017 | 191 | 0.470 |
Why?
|
Cranial Nerve Diseases | 2 | 2012 | 26 | 0.460 |
Why?
|
Blood Volume | 1 | 2014 | 81 | 0.450 |
Why?
|
Rhabdoid Tumor | 1 | 2013 | 53 | 0.420 |
Why?
|
Diagnostic Errors | 1 | 2017 | 334 | 0.410 |
Why?
|
Mutism | 2 | 2024 | 31 | 0.410 |
Why?
|
Meglumine | 3 | 2018 | 15 | 0.400 |
Why?
|
Infant, Newborn | 9 | 2024 | 8268 | 0.400 |
Why?
|
Teratoma | 1 | 2013 | 126 | 0.390 |
Why?
|
Medulloblastoma | 3 | 2024 | 543 | 0.390 |
Why?
|
Organometallic Compounds | 3 | 2018 | 111 | 0.380 |
Why?
|
Oculomotor Muscles | 1 | 2012 | 64 | 0.380 |
Why?
|
Orbital Diseases | 1 | 2012 | 91 | 0.370 |
Why?
|
Mitochondrial Diseases | 2 | 2024 | 132 | 0.360 |
Why?
|
Cerebellar Diseases | 2 | 2022 | 74 | 0.360 |
Why?
|
Diffusion Tensor Imaging | 3 | 2023 | 240 | 0.350 |
Why?
|
Cerebellar Neoplasms | 2 | 2024 | 439 | 0.310 |
Why?
|
Hematoma, Subdural | 2 | 2019 | 20 | 0.300 |
Why?
|
Atlanto-Occipital Joint | 1 | 2008 | 6 | 0.290 |
Why?
|
Chondrocalcinosis | 1 | 2008 | 13 | 0.290 |
Why?
|
Optic Nerve Glioma | 2 | 2019 | 21 | 0.290 |
Why?
|
Atlanto-Axial Joint | 1 | 2008 | 21 | 0.290 |
Why?
|
Spinal Diseases | 2 | 2018 | 45 | 0.280 |
Why?
|
Skull | 3 | 2022 | 141 | 0.250 |
Why?
|
Spasms, Infantile | 2 | 2017 | 172 | 0.240 |
Why?
|
Observer Variation | 2 | 2017 | 300 | 0.240 |
Why?
|
Spinal Injuries | 2 | 2022 | 28 | 0.230 |
Why?
|
Ventral Thalamic Nuclei | 1 | 2024 | 16 | 0.220 |
Why?
|
Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.220 |
Why?
|
Fever | 2 | 2024 | 300 | 0.220 |
Why?
|
Tuberculosis, Spinal | 1 | 2023 | 8 | 0.220 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2023 | 10 | 0.220 |
Why?
|
Positron-Emission Tomography | 2 | 2016 | 306 | 0.220 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2023 | 27 | 0.210 |
Why?
|
Hysterotomy | 1 | 2024 | 126 | 0.210 |
Why?
|
Laparotomy | 1 | 2024 | 135 | 0.210 |
Why?
|
Tuberculosis, Meningeal | 1 | 2023 | 29 | 0.210 |
Why?
|
Acidosis, Lactic | 1 | 2023 | 30 | 0.210 |
Why?
|
MELAS Syndrome | 1 | 2023 | 33 | 0.210 |
Why?
|
Arnold-Chiari Malformation | 1 | 2024 | 49 | 0.210 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 2023 | 5 | 0.210 |
Why?
|
Circulating Tumor DNA | 1 | 2023 | 35 | 0.200 |
Why?
|
Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 30 | 0.200 |
Why?
|
Spinal Cord Neoplasms | 1 | 2023 | 72 | 0.200 |
Why?
|
Facial Paralysis | 1 | 2022 | 35 | 0.200 |
Why?
|
Optic Atrophy | 1 | 2023 | 47 | 0.200 |
Why?
|
Cerebral Ventricles | 2 | 2023 | 82 | 0.200 |
Why?
|
Skull Base Neoplasms | 1 | 2022 | 36 | 0.200 |
Why?
|
Neural Pathways | 1 | 2024 | 268 | 0.200 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 2022 | 31 | 0.200 |
Why?
|
Reproducibility of Results | 4 | 2017 | 2904 | 0.200 |
Why?
|
Diffuse Axonal Injury | 1 | 2022 | 10 | 0.200 |
Why?
|
Fourth Ventricle | 1 | 2022 | 11 | 0.190 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2022 | 8 | 0.190 |
Why?
|
Sphingosine | 1 | 2001 | 12 | 0.190 |
Why?
|
Cerebellar Ataxia | 1 | 2022 | 66 | 0.190 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2001 | 7 | 0.190 |
Why?
|
Hemangioma | 1 | 2022 | 94 | 0.190 |
Why?
|
Anemia, Sideroblastic | 1 | 2021 | 17 | 0.180 |
Why?
|
Lysophospholipids | 1 | 2001 | 28 | 0.180 |
Why?
|
Middle Aged | 8 | 2024 | 26827 | 0.180 |
Why?
|
Dermoid Cyst | 1 | 2021 | 34 | 0.180 |
Why?
|
Solvents | 1 | 2001 | 44 | 0.180 |
Why?
|
Scalp | 1 | 2021 | 57 | 0.180 |
Why?
|
Meningomyelocele | 1 | 2024 | 250 | 0.180 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2021 | 22 | 0.180 |
Why?
|
Purpura | 1 | 2021 | 24 | 0.180 |
Why?
|
Microcephaly | 1 | 2024 | 331 | 0.180 |
Why?
|
Neurofibroma, Plexiform | 1 | 2020 | 7 | 0.180 |
Why?
|
Adaptation, Psychological | 1 | 2024 | 449 | 0.180 |
Why?
|
Language Development Disorders | 1 | 2022 | 175 | 0.170 |
Why?
|
Head | 2 | 2022 | 104 | 0.170 |
Why?
|
Paranasal Sinuses | 1 | 2020 | 19 | 0.170 |
Why?
|
Neural Tube Defects | 1 | 2024 | 356 | 0.170 |
Why?
|
Fetoscopy | 1 | 2024 | 447 | 0.170 |
Why?
|
Neurovascular Coupling | 1 | 2019 | 10 | 0.170 |
Why?
|
Streptococcus pneumoniae | 1 | 2022 | 376 | 0.170 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2023 | 224 | 0.160 |
Why?
|
Adult | 9 | 2023 | 29635 | 0.160 |
Why?
|
Brain Infarction | 1 | 2019 | 31 | 0.160 |
Why?
|
Occipital Lobe | 1 | 2019 | 32 | 0.160 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2019 | 40 | 0.160 |
Why?
|
Diagnostic Imaging | 2 | 2022 | 280 | 0.160 |
Why?
|
Sinusitis | 1 | 2020 | 116 | 0.150 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 171 | 0.150 |
Why?
|
Leukocyte Count | 1 | 2019 | 251 | 0.150 |
Why?
|
Iopamidol | 1 | 2018 | 5 | 0.150 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 14 | 0.150 |
Why?
|
Injections, Intra-Articular | 1 | 2018 | 26 | 0.150 |
Why?
|
Gadolinium DTPA | 1 | 2018 | 47 | 0.150 |
Why?
|
Gray Matter | 1 | 2018 | 32 | 0.150 |
Why?
|
Neurofibromatosis 1 | 1 | 2019 | 63 | 0.150 |
Why?
|
Brain Diseases | 1 | 2021 | 300 | 0.140 |
Why?
|
Follow-Up Studies | 5 | 2024 | 5174 | 0.140 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 774 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 1 | 2017 | 52 | 0.140 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2018 | 88 | 0.140 |
Why?
|
Craniopharyngioma | 1 | 2017 | 34 | 0.140 |
Why?
|
Nystagmus, Pathologic | 1 | 2017 | 22 | 0.130 |
Why?
|
Escherichia coli | 1 | 2022 | 984 | 0.130 |
Why?
|
Area Under Curve | 1 | 2017 | 318 | 0.130 |
Why?
|
Myelography | 1 | 2016 | 9 | 0.130 |
Why?
|
Radiotherapy Dosage | 1 | 2017 | 187 | 0.130 |
Why?
|
Spinal Cord | 2 | 2023 | 305 | 0.130 |
Why?
|
Aged | 4 | 2024 | 19739 | 0.130 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2016 | 43 | 0.130 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 206 | 0.130 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 71 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2017 | 236 | 0.130 |
Why?
|
Time Factors | 2 | 2017 | 6324 | 0.130 |
Why?
|
Anesthesia, General | 1 | 2017 | 117 | 0.130 |
Why?
|
White Matter | 1 | 2018 | 184 | 0.130 |
Why?
|
Optic Nerve | 1 | 2017 | 114 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2019 | 3310 | 0.120 |
Why?
|
Neck | 1 | 2016 | 135 | 0.120 |
Why?
|
Intellectual Disability | 1 | 2023 | 1054 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2023 | 860 | 0.120 |
Why?
|
Canavan Disease | 1 | 2014 | 1 | 0.120 |
Why?
|
Goldenhar Syndrome | 1 | 2014 | 12 | 0.120 |
Why?
|
Ear, Middle | 1 | 2014 | 25 | 0.120 |
Why?
|
Cognitive Dysfunction | 1 | 2018 | 236 | 0.120 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2014 | 8 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2014 | 49 | 0.110 |
Why?
|
Ultrasonography | 1 | 2019 | 939 | 0.110 |
Why?
|
Anticoagulants | 3 | 2024 | 578 | 0.110 |
Why?
|
Chemoradiotherapy | 1 | 2015 | 104 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2015 | 183 | 0.110 |
Why?
|
Software | 1 | 2018 | 687 | 0.110 |
Why?
|
Mass Screening | 1 | 2019 | 785 | 0.110 |
Why?
|
Aged, 80 and over | 3 | 2017 | 6558 | 0.110 |
Why?
|
Syndrome | 3 | 2022 | 1122 | 0.110 |
Why?
|
Image Enhancement | 1 | 2014 | 163 | 0.110 |
Why?
|
World Health Organization | 1 | 2013 | 107 | 0.110 |
Why?
|
Brain Concussion | 1 | 2016 | 228 | 0.100 |
Why?
|
Incidence | 2 | 2024 | 3135 | 0.100 |
Why?
|
Accidental Falls | 1 | 2014 | 104 | 0.100 |
Why?
|
Artifacts | 1 | 2013 | 109 | 0.100 |
Why?
|
Seizures | 3 | 2024 | 871 | 0.100 |
Why?
|
Spinal Cord Diseases | 1 | 2012 | 38 | 0.100 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 503 | 0.090 |
Why?
|
Arteriovenous Fistula | 1 | 2012 | 55 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2014 | 463 | 0.090 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 2183 | 0.090 |
Why?
|
Cervical Vertebrae | 2 | 2018 | 113 | 0.090 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 1070 | 0.090 |
Why?
|
Cerebral Cortex | 1 | 2013 | 455 | 0.090 |
Why?
|
Prevalence | 1 | 2017 | 2469 | 0.080 |
Why?
|
Young Adult | 3 | 2019 | 9085 | 0.080 |
Why?
|
Anisotropy | 2 | 2019 | 124 | 0.080 |
Why?
|
Paresthesia | 1 | 2008 | 7 | 0.070 |
Why?
|
Odontoid Process | 1 | 2008 | 10 | 0.070 |
Why?
|
Hypesthesia | 1 | 2008 | 10 | 0.070 |
Why?
|
Ligaments, Articular | 1 | 2008 | 22 | 0.070 |
Why?
|
Neck Pain | 1 | 2008 | 18 | 0.070 |
Why?
|
Cerebellum | 2 | 2022 | 440 | 0.070 |
Why?
|
Spinal Fusion | 1 | 2008 | 114 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 1830 | 0.070 |
Why?
|
Risk Factors | 2 | 2024 | 10298 | 0.070 |
Why?
|
Pregnancy | 3 | 2024 | 7222 | 0.070 |
Why?
|
Calcinosis | 1 | 2008 | 180 | 0.060 |
Why?
|
Prospective Studies | 1 | 2017 | 6174 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 1714 | 0.060 |
Why?
|
Skull Neoplasms | 1 | 2005 | 14 | 0.060 |
Why?
|
Chordoma | 1 | 2005 | 21 | 0.060 |
Why?
|
Mutation | 3 | 2023 | 5903 | 0.060 |
Why?
|
Spinal Neoplasms | 1 | 2005 | 59 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2023 | 21 | 0.050 |
Why?
|
Meninges | 1 | 2023 | 20 | 0.050 |
Why?
|
Skull Base | 1 | 2024 | 53 | 0.050 |
Why?
|
Neurosurgery | 1 | 2005 | 77 | 0.050 |
Why?
|
Cerebral Aqueduct | 1 | 2023 | 10 | 0.050 |
Why?
|
Subarachnoid Space | 1 | 2023 | 24 | 0.050 |
Why?
|
Spin Labels | 1 | 2023 | 38 | 0.050 |
Why?
|
Phenotype | 2 | 2024 | 4269 | 0.050 |
Why?
|
Surface Plasmon Resonance | 1 | 2022 | 47 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2024 | 187 | 0.050 |
Why?
|
Cohort Studies | 2 | 2024 | 4843 | 0.050 |
Why?
|
Prognosis | 2 | 2024 | 4690 | 0.050 |
Why?
|
COUP Transcription Factor I | 1 | 2023 | 91 | 0.050 |
Why?
|
Facial Nerve | 1 | 2022 | 25 | 0.050 |
Why?
|
Cytarabine | 1 | 2023 | 95 | 0.050 |
Why?
|
Decision Making | 1 | 2008 | 657 | 0.050 |
Why?
|
Citrulline | 1 | 2023 | 111 | 0.050 |
Why?
|
Glutathione | 1 | 2023 | 195 | 0.050 |
Why?
|
Propranolol | 1 | 2022 | 128 | 0.050 |
Why?
|
Remission Induction | 1 | 2023 | 292 | 0.050 |
Why?
|
Cranial Sinuses | 1 | 2022 | 12 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 148 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2005 | 306 | 0.050 |
Why?
|
Chloroform | 1 | 2001 | 4 | 0.050 |
Why?
|
Micelles | 1 | 2001 | 16 | 0.050 |
Why?
|
Chromatography, Thin Layer | 1 | 2001 | 46 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 43 | 0.050 |
Why?
|
Brain Stem | 1 | 2022 | 117 | 0.050 |
Why?
|
Emotions | 1 | 2024 | 358 | 0.050 |
Why?
|
Arginine | 1 | 2023 | 335 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 74 | 0.050 |
Why?
|
Medical Oncology | 1 | 2022 | 220 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2024 | 3055 | 0.040 |
Why?
|
Time | 1 | 2021 | 92 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2024 | 12303 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2023 | 762 | 0.040 |
Why?
|
Gestational Age | 1 | 2024 | 1169 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 922 | 0.040 |
Why?
|
Research | 1 | 2022 | 262 | 0.040 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2020 | 57 | 0.040 |
Why?
|
Ethanol | 1 | 2001 | 162 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2019 | 22 | 0.040 |
Why?
|
Central Venous Pressure | 1 | 2018 | 26 | 0.040 |
Why?
|
Temporal Lobe | 1 | 2019 | 113 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2018 | 94 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2018 | 98 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 887 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2020 | 674 | 0.030 |
Why?
|
Emergencies | 1 | 2018 | 172 | 0.030 |
Why?
|
Mitochondria | 1 | 2022 | 679 | 0.030 |
Why?
|
Nerve Net | 1 | 2018 | 243 | 0.030 |
Why?
|
Biomarkers, Tumor | 1 | 2023 | 1534 | 0.030 |
Why?
|
Ear Ossicles | 1 | 2014 | 2 | 0.030 |
Why?
|
Temporomandibular Joint | 1 | 2014 | 10 | 0.030 |
Why?
|
Ear Canal | 1 | 2014 | 9 | 0.030 |
Why?
|
Amidohydrolases | 1 | 2014 | 23 | 0.030 |
Why?
|
Atrophy | 1 | 2014 | 231 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2014 | 295 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 2429 | 0.020 |
Why?
|
Foramen Magnum | 1 | 2005 | 5 | 0.010 |
Why?
|
Plasmacytoma | 1 | 2005 | 7 | 0.010 |
Why?
|
Meningioma | 1 | 2005 | 121 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2005 | 427 | 0.010 |
Why?
|